Fengycin is a type of lipopeptide antibiotic produced by certain strains of the bacterium Bacillus subtilis. It is known for its ability to inhibit the growth of various harmful bacteria, making it a potential candidate for agricultural and medical applications. Fengycin works by disrupting the cell membranes of target bacteria, leading to their death. Research has shown that Fengycin is effective against a range of pathogens, including Staphylococcus aureus and Listeria monocytogenes. Its unique structure allows it to form pores in bacterial membranes, which enhances its antimicrobial properties. This makes Fengycin an important focus in the development of new antimicrobial agents.